| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/13/1994 | EP0591385A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 04/13/1994 | EP0591374A1 Nanoparticles based on a polyoxyethylene and polylactic acid block copolymer |
| 04/13/1994 | EP0591369A1 Capsid forming and cystein modified chimaeric ms2-coat protein |
| 04/13/1994 | EP0591363A1 Pharmaceutical preparations containing torasemid |
| 04/13/1994 | EP0591346A1 Process for solubilizing difficultly soluble pharmaceutical actives |
| 04/13/1994 | EP0591331A1 Method of preparing nanoparticles. |
| 04/13/1994 | EP0591284A1 Carrier systems for drugs |
| 04/13/1994 | EP0591204A1 Pharmaceutical formulations. |
| 04/13/1994 | EP0540580B1 Polymeric drug delivery system |
| 04/13/1994 | CN1085082A Vitamin E drop |
| 04/13/1994 | CN1085081A Pharmaceutical and other dosage forms |
| 04/12/1994 | US5302715 For binding to antigens, proteins, polypeptides or other labels for preparation of antibodies useful in immunoassays |
| 04/12/1994 | US5302714 Sapphyrins, derivatives and syntheses |
| 04/12/1994 | US5302610 Renal-selective biphenylmethyl imidazole angiotensin II antagonists for treatment of hypertension |
| 04/12/1994 | US5302581 Administering with lipids for the treatment of respiratory disease |
| 04/12/1994 | US5302516 Catalytic and reactive polypeptides and methods for their preparation and use |
| 04/12/1994 | US5302401 Method to reduce particle size growth during lyophilization |
| 04/12/1994 | US5302399 Slow-releasing pharmaceuticals prepared with alginic acid |
| 04/12/1994 | US5302398 Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids |
| 04/12/1994 | US5302396 Superior tasting composition having porous particles and the process of preparing such pharmaceutical composition |
| 04/12/1994 | US5302395 Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes |
| 04/12/1994 | US5302369 Microspheres for radiation therapy |
| 04/12/1994 | US5302172 Method and composition for iontophoresis |
| 04/12/1994 | CA1328402C Somatostatins |
| 04/06/1994 | EP0590786A1 Use of certain anionic surfactants to enhance antimicrobial effectiveness of opthalmic compositions |
| 04/06/1994 | EP0590655A1 Muco-adhesive polymers |
| 04/06/1994 | EP0590531A1 Antithrombin III preparation |
| 04/06/1994 | EP0590109A1 $i(IN VIVO) BINDING PAIR PRETARGETING |
| 04/06/1994 | EP0590038A1 Amino acid derivative and bromoacetyl modified peptides |
| 04/06/1994 | EP0590011A1 Abrin variants and immunnotoxins |
| 04/06/1994 | EP0589871A1 Peritoneal induced medicaments |
| 04/06/1994 | EP0536204B1 The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations |
| 04/06/1994 | EP0417256B1 Novel n-(sulfomethyl)-n'-arylureas |
| 04/06/1994 | EP0409936B1 Process for producing aqueous mixed micelle solutions |
| 04/06/1994 | EP0355152B1 Topical metronidazole formulations and therapeutic uses thereof |
| 04/06/1994 | EP0353295B1 Novel and improved antibodies for site specific attachment of compounds |
| 04/06/1994 | CN1084844A Methods for manufacturing mixtures of higher alphathic alcohols for pharmaceutical compositions |
| 04/06/1994 | CN1084742A Pharmaceutical and/or cosmetic composition and the use thereof |
| 04/06/1994 | CA2107598A1 Ointment for treatment of epithelial lesions |
| 04/06/1994 | CA2107410A1 Stable magnesium hydroxide slurries |
| 04/05/1994 | US5300528 Use of perfluoroethyldimethyl cyclohexane for oxygen transport |
| 04/05/1994 | US5300494 Delivery systems for quaternary and related compounds |
| 04/05/1994 | US5300318 Process for polishing granulates of active principles |
| 04/05/1994 | US5300302 Pharmaceutical composition in gel form in a dispensing package |
| 04/05/1994 | US5300295 Ophthalmic drug delivery with thermoreversible polyoxyalkylene gels adjustable for pH |
| 04/05/1994 | US5300288 Acrylic amide polymers |
| 04/05/1994 | US5299566 Heating aqueous dispersion containing surfactant, nebulizing delivering to lungs |
| 04/05/1994 | CA1328219C Oral form for administering carbamazepine with delay release |
| 04/05/1994 | CA1328218C Controlled release formulation |
| 03/31/1994 | WO1994006903A1 Delivery of proteins by intermembrane transfer for preaccommodation of xenogeneic organ transplants and other purposes |
| 03/31/1994 | WO1994006472A1 Antigen-carrying microparticles and their use in the induction of humoral or cellular responses |
| 03/31/1994 | WO1994006467A1 Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines |
| 03/31/1994 | WO1994006457A1 Pharmaceutical formulations of interleukin-1 inhibitors |
| 03/31/1994 | WO1994006452A1 Sustained-release protein formulations |
| 03/31/1994 | WO1994006444A1 Germicidal detergent-iodine compositions having reduced detergent content |
| 03/31/1994 | WO1994006437A1 Subcutaneous implants based on nomegestrol derivatives |
| 03/31/1994 | WO1994006436A1 Dexpanthenol-containing plaster for the transdermal application of steroid hormones |
| 03/31/1994 | WO1994006434A1 Method and composition for the treatment of hair loss |
| 03/31/1994 | WO1994006414A1 Sustained-release hydrogel preparation |
| 03/31/1994 | WO1994006408A1 Water-in-oil emulsions containing water-soluble alkyl glycosides |
| 03/31/1994 | WO1994006310A1 Novel compositions |
| 03/31/1994 | WO1994006296A1 Iodine/resin disinfectant and a procedure for the preparation thereof |
| 03/31/1994 | WO1994003610A3 Isolation and cloning of a protein with tyrosine-phosphatase activity |
| 03/31/1994 | DE4303818C1 Sterile medicament for topical admin. of dexpanthenol - contg. a polyacrylate carrier to improve stability of active agent |
| 03/31/1994 | CA2144767A1 Delivery of proteins by intermembrane transfer for preaccommodation of xenogeneic organ transplants and other purposes |
| 03/31/1994 | CA2144083A1 Aqueous composition for preparation of an optically clear product and process for preparation thereof |
| 03/31/1994 | CA2143289A1 Water-in-oil emulsions containing water-soluble alkyl glycosides |
| 03/31/1994 | CA2122827A1 Nomegestrol derivatives-based subcutaneous implants |
| 03/30/1994 | EP0589843A1 Pharmaceutical compositions containing cyclosporins |
| 03/30/1994 | EP0589840A1 Reshaped monoclonal antibodies against an immunoglobulin isotype |
| 03/30/1994 | EP0589556A2 Carbohydrate-based anti-inflammatory agents |
| 03/30/1994 | EP0589375A1 Micronutrient compositions |
| 03/30/1994 | EP0588869A1 X-ray contrast agent |
| 03/30/1994 | CN1084410A Improvements in or relating to contrast agents |
| 03/30/1994 | CN1084391A Surface modified anticancer nanoparticles |
| 03/29/1994 | US5298569 Metallic ester acrylic compositions capable of releasing bioactive substance at a controlled rate |
| 03/29/1994 | US5298496 Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same |
| 03/29/1994 | US5298488 Inhibiting cell adhesion and anticoagulants |
| 03/29/1994 | US5298410 Conjugated with superoxide dismutase protein |
| 03/29/1994 | US5298409 Antibody-enhanced stereospecific hydrolyses |
| 03/29/1994 | US5298262 Use of ionic cloud point modifiers to prevent particle aggregation during sterilization |
| 03/29/1994 | US5298260 Topical drug delivery with polyoxyalkylene polymer thermoreversible gels adjustable for pH and osmolality |
| 03/29/1994 | US5298257 Controlled transdermal nicotine delivery; anti-irritant |
| 03/29/1994 | US5298243 Colony stimulating factor-gelatin conjugate |
| 03/29/1994 | US5298239 Mutations rendering platelet glycoprotein IB α less reactive |
| 03/29/1994 | CA2099427A1 Indications for carnitine |
| 03/29/1994 | CA1328078C Aqueous formulations containing a piperidinylcyclopentylheptenoic acid derivative |
| 03/29/1994 | CA1328072C Sustained-release preparation and production thereof |
| 03/24/1994 | DE4231596A1 3'-azido:thymidinyl:carbonyl-LDL prepn using p-nitrophenyl:formyl chloride - useful in targetted treatment of HIV with reduced side effects |
| 03/23/1994 | EP0588578A1 Immunogens |
| 03/23/1994 | EP0588539A1 Stabilized pharmaceutical compositions containing derivatives of vitamins D2 and D3 |
| 03/23/1994 | EP0588474A1 A psyllium-gum arabic compostion |
| 03/23/1994 | EP0588255A1 Physiologically active peptide compositions |
| 03/23/1994 | EP0587858A1 Protein formulation comprising growth hormone |
| 03/23/1994 | EP0587840A1 Bioartificial endocrine device |
| 03/23/1994 | EP0587749A1 Compositions and delivery systems for transdermal administration of neutral oligomers |
| 03/23/1994 | EP0587744A1 Chewable drug-delivery composition |
| 03/23/1994 | EP0587738A1 Targeted delivery of genes encoding secretory proteins |
| 03/23/1994 | EP0587715A1 Water insoluble derivatives of polyanionic polysaccharides |
| 03/23/1994 | EP0587659A1 Pharmaceutical carrier. |